» Articles » PMID: 23940809

Clonal Expansion Analysis of Transposon Insertions by High-throughput Sequencing Identifies Candidate Cancer Genes in a PiggyBac Mutagenesis Screen

Overview
Journal PLoS One
Date 2013 Aug 14
PMID 23940809
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Somatic transposon mutagenesis in mice is an efficient strategy to investigate the genetic mechanisms of tumorigenesis. The identification of tumor driving transposon insertions traditionally requires the generation of large tumor cohorts to obtain information about common insertion sites. Tumor driving insertions are also characterized by their clonal expansion in tumor tissue, a phenomenon that is facilitated by the slow and evolving transformation process of transposon mutagenesis. We describe here an improved approach for the detection of tumor driving insertions that assesses the clonal expansion of insertions by quantifying the relative proportion of sequence reads obtained in individual tumors. To this end, we have developed a protocol for insertion site sequencing that utilizes acoustic shearing of tumor DNA and Illumina sequencing. We analyzed various solid tumors generated by PiggyBac mutagenesis and for each tumor >10⁶ reads corresponding to >10⁴ insertion sites were obtained. In each tumor, 9 to 25 insertions stood out by their enriched sequence read frequencies when compared to frequencies obtained from tail DNA controls. These enriched insertions are potential clonally expanded tumor driving insertions, and thus identify candidate cancer genes. The candidate cancer genes of our study comprised many established cancer genes, but also novel candidate genes such as Mastermind-like1 (Mamld1) and Diacylglycerolkinase delta (Dgkd). We show that clonal expansion analysis by high-throughput sequencing is a robust approach for the identification of candidate cancer genes in insertional mutagenesis screens on the level of individual tumors.

Citing Articles

Using Genome Scale Mutant Libraries to Identify Essential Genes.

Myers K, Lal P, Noguera D, Donohue T Methods Mol Biol. 2021; 2377:215-236.

PMID: 34709619 DOI: 10.1007/978-1-0716-1720-5_12.


Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.

Aiderus A, Newberg J, Guzman-Rojas L, Contreras-Sandoval A, Meshey A, Jones D PLoS Genet. 2021; 17(8):e1009094.

PMID: 34398873 PMC: 8389471. DOI: 10.1371/journal.pgen.1009094.


In vivo functional screening for systems-level integrative cancer genomics.

Weber J, Braun C, Saur D, Rad R Nat Rev Cancer. 2020; 20(10):573-593.

PMID: 32636489 DOI: 10.1038/s41568-020-0275-9.


Transposon Insertion Mutagenesis in Mice for Modeling Human Cancers: Critical Insights Gained and New Opportunities.

Beckmann P, Largaespada D Int J Mol Sci. 2020; 21(3).

PMID: 32050713 PMC: 7036786. DOI: 10.3390/ijms21031172.


Arrayed mutant haploid embryonic stem cell libraries facilitate phenotype-driven genetic screens.

Liu G, Wang X, Liu Y, Zhang M, Cai T, Shen Z Nucleic Acids Res. 2017; 45(22):e180.

PMID: 29036617 PMC: 5727442. DOI: 10.1093/nar/gkx857.


References
1.
Griner E, Kazanietz M . Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007; 7(4):281-94. DOI: 10.1038/nrc2110. View

2.
Quail M, Swerdlow H, Turner D . Improved protocols for the illumina genome analyzer sequencing system. Curr Protoc Hum Genet. 2009; Chapter 18:Unit 18.2. PMC: 3849550. DOI: 10.1002/0471142905.hg1802s62. View

3.
Dupuy A, Akagi K, Largaespada D, Copeland N, Jenkins N . Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature. 2005; 436(7048):221-6. DOI: 10.1038/nature03691. View

4.
Wang W, Lin C, Lu D, Ning Z, Cox T, Melvin D . Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2008; 105(27):9290-5. PMC: 2440425. DOI: 10.1073/pnas.0801017105. View

5.
Brett B, Berquam-Vrieze K, Nannapaneni K, Huang J, Scheetz T, Dupuy A . Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS One. 2011; 6(9):e24668. PMC: 3172244. DOI: 10.1371/journal.pone.0024668. View